4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-030190
General Counsel and Secretary sold 3,947 shares at an average $77.15 ($304,515)
- General Counsel and Secretary acquired 7,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2024-03-10 | Option exercise | +5,500 | 62,871 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2024-03-11 | Sale | −2,801 | $78.26 | $219,206 | 60,070 | D |
| KASINGER JAMES R. General Counsel and Secretary | 2024-03-11 | Option exercise | +2,250 | 62,320 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2024-03-12 | Sale | −1,146 | $74.44 | $85,308 | 61,174 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2024-03-10 | Option exercise · Restricted Stock Units | −5,500 | 16,500 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2024-03-11 | Option exercise · Restricted Stock Units | −2,250 | 2,250 | D | ||
| Open-market sales · 3,947 sh · avg $77.15 · $304,515 | |||||||
Loading xslF345X05/ownership.xml…